Evicenter
Enhertu (fam-trastuzumab deruxtecan-nxki), All indications
Manufacturer
Daiichi Sankyo, Inc.; AstraZeneca Pharmaceuticals LP
Prescribing information
Enhertu (opens in a new tab)
Questions
31
Last updated

All questions

Safety: Enhertu (fam-trastuzumab deruxtecan-nxki), all indications

4 questions · 4 sources

Warnings

What is the Enhertu boxed warning for lung disease and pregnancy?

Does Enhertu have contraindications?

Safety management

How is interstitial lung disease (ILD) managed with Enhertu?

Administration reactions

What should be done if an Enhertu infusion reaction occurs?

Note: The second passage is from DESTINY-Breast06 (ENHERTU n=434) and includes infusion-related reactions (1.2%).